Artificial intelligence for prostate MRI: open datasets, available applications, and grand challenges.

Mohammed R S Sunoqrot1,2, Anindo Saha3, Matin Hosseinzadeh3

  • 1Department of Circulation and Medical Imaging, NTNU-Norwegian University of Science and Technology, 7030, Trondheim, Norway. mohammed.sunoqrot@ntnu.no.

Summary

Artificial intelligence (AI) is emerging in prostate cancer (PCa) diagnosis using MRI, offering workflow efficiencies. Further validation on diverse datasets is crucial for broader clinical adoption and exploring AI in other PCa stages.